Published 2 days ago • loading... • Updated 1 day ago

AI Tool Accurately Predicts Prostate Cancer Outcomes Across Racial Groups

Summary by targetedonc.com

Mack Roach III, MD, discusses the development and evaluation of a multimodal AI algorithm designed to predict prostate cancer outcomes and its performance across racial subgroups.

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

3 Articles

All

Left

Center

Right

targetedonc.com

AI Tool Accurately Predicts Prostate Cancer Outcomes Across Racial Groups

Mack Roach III, MD, discusses the development and evaluation of a multimodal AI algorithm designed to predict prostate cancer outcomes and its performance across racial subgroups.

1 day ago

Read Full Article

pharmafile.com

Johnson & Johnson seeks EMA approval to accelerate prostate cancer treatment - Pharmafile

Johnson & Johnson has submitted an application to the European Medicines Agency for an indication extension of Akeega (niraparib and abiraterone acetate dual action tablet), aiming to treat adult patients with metastatic hormone-sensitive prostate cancer who carry homologous recombination repair (HRR) gene alterations. The submission builds on positive results from the company’s phase 3 AMPLITUDE […] The post Johnson & Johnson seeks EMA approval…

1 day ago

Read Full Article

curetoday.com

How Multidisciplinary Care Impacts Prostate Cancer Treatment

Multidisciplinary care, a collaborative approach where various healthcare disciplines come together, is essential for treating those with prostate cancer.

2 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year